Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (148)

« Back to Publications

Metabolism in Tumour-Induced Bone Disease.

Ormsby RT. and Edwards CM., (2026), Curr Osteoporos Rep, 24

High-cholesterol diet fuels myeloma progression, dysregulates adipokine expression in vivo, and impairs treatment response ex vivo.

Gámez B. et al, (2026), Haematologica

Circulating tumour cells as a window into lethality in prostate cancer.

Abusamra SM. et al, (2026), Nat Rev Urol

Medical Students' Observations of High Value and Potentially Wasteful Care Behaviors Modeled During Clinical Rotations.

Wade A. et al, (2025), J Gen Intern Med, 40, 1758 - 1767

pplying Fluid-Walled Microfluidic Technology to Investigate the Niche Tumor Bone Microenvironment in ProstateCancer Bone Metastasis

Aleezada Z. et al, (2025), SOUTHERN MEDICAL JOURNAL, 118

PKCδ Neurons in the Bed Nucleus of the Stria Terminalis Exhibit Dysregulated Activity following Chronic Ethanol Exposure

Doyle M. et al, (2025), JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 392

ISB 2001 trispecific T cell engager shows strong tumor cytotoxicity and overcomes immune escape mechanisms of multiple myeloma cells.

Carretero-Iglesia L. et al, (2024), Nat Cancer, 5, 1494 - 1514

Novel Mouse Home Cage Lickometer System Reveals Sex- and Housing-Based Influences on Alcohol Drinking.

Petersen N. et al, (2024), eNeuro, 11

Editors' introduction: The microenvironment in bone metastasis - New dimensions.

Holen I. and Edwards C., (2024), J Bone Oncol, 48

Determining how prostate cancer cell heterogeneity promotes bone metastasis using fluid-walled microfluidics

Cotton D. et al, (2024), Journal of Bone Oncology, 45

The integrated on-chip isolation and detection of circulating tumour cells.

Abusamra SM. et al, (2024), Sens Diagn, 3, 562 - 584

Development of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myeloma.

Grandclément C. et al, (2024), Nat Commun, 15

ntibody-Based Imaging of Bioreductive Prodrug Release in Hypoxia.

Tosun Ç. et al, (2023), JACS Au, 3, 3237 - 3246

Preclinical characterization of ISB 1342, a CD38 × CD3 T-cell engager for relapsed/refractory multiple myeloma.

Pouleau B. et al, (2023), Blood, 142, 260 - 273

dipocyte autophagy limits gut inflammation by controlling oxylipin and IL-10.

Richter FC. et al, (2023), EMBO J, 42

Load More

1
2
3
4
5
6
7
...
»